Autoimmune Conditions

One-fifth of hospitalized patients develop coronavirus antibodies that attack their tissue

Excerpts from 'The Puzzle Solver'

The brain is a new frontier for cancer immunotherapy

Ulcerative colitis patients could be missing a key intestinal microbe

A sampler of COVID-19 research

Stanford launched its own test early in the pandemic — but the challenges kept on coming

Stanford researchers stand at the forefront of efforts to defeat the disease

Stimulating cells that jump in to protect healthy tissues in MS patients when their immune systems attack could lead to new drug therapies, researcher says.

The experimental drug filgotinib blocks a set of enzymes that cause inflammation in rheumatoid arthritis patients who haven’t benefitted from other treatments, a study shows.